First new treatment for osteoporosis for over a decade
Thousands of people in England and Wales with severe osteoporosis who are at high risk of fracture are set to benefit from a new treatment – romosozumab (Evenity™,… read more.
Thousands of people in England and Wales with severe osteoporosis who are at high risk of fracture are set to benefit from a new treatment – romosozumab (Evenity™,… read more.
The menopause transition is associated with several health issues. The incidence of both sleep apnea and joint pain, for example, are higher in postmenopausal women. A new study… read more.
Channels on the surface of bone cells called osteocytes help build stronger bones in response to mechanical stress, shows a study published today in eLife. This discovery may help… read more.
Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure, is likely caused by infection with the Epstein-Barr… read more.
A decline in metabolism and endurance of skeletal muscle is commonly observed in obese patients, but the underlying mechanism is not well-understood. A research team led by Dr… read more.
Fractures of the clavicle, or collarbone, are common. Unfortunately, current fixation plates that are used to surgically stabilize these fractures are suboptimal, leading to reoperation rates of up… read more.
Same-day discharge after total knee arthroplasty (TKA) or total hip arthroplasty (THA) is safe in some patients classified as “high risk” – with no increase in complications or other… read more.
Radius Health announced positive topline results from the ATOM study evaluating Tymlos (abaloparatide) 80mcg subcutaneous (SC) for use in males with osteoporosis. The ATOM study met its primary… read more.
Mesenchymal stem cells (MSCs) are thought to have great potential in the field of regenerative medicine, which has the aim of restoring damaged tissues. However, not much was… read more.
The International Osteoporosis Foundation’s (IOF) Capture the Fracture® program has launched a new, enhanced online platform to enable coordinated post-fracture care services (including ‘Fracture Liaison Services’, or FLS) to… read more.
Treatment with alendronate, an osteoporosis drug, appears to reduce the risk of developing type 2 diabetes, researchers reported on Sept. 26, 2021 at the annual meeting of the… read more.
Chronic back pain affects upwards of 15 million adults in the US, racking up billions in healthcare costs and lost work days. Degeneration of the discs that cushion… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.